DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 146 filers reported holding DICERNA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 3.99 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $6,579,000 | -12.8% | 176,277 | -40.3% | 0.01% | -20.0% |
| Q1 2021 | $7,545,000 | -28.5% | 295,054 | -38.4% | 0.01% | +42.9% |
| Q4 2020 | $10,548,000 | +148.3% | 478,786 | +103.8% | 0.01% | 0.0% |
| Q3 2020 | $4,248,000 | -23.8% | 234,938 | +7.0% | 0.01% | -30.0% |
| Q2 2020 | $5,576,000 | +22.9% | 219,514 | -4.2% | 0.01% | 0.0% |
| Q1 2020 | $4,537,000 | +87.8% | 229,039 | +108.8% | 0.01% | +150.0% |
| Q4 2019 | $2,416,000 | +47.8% | 109,690 | +1.8% | 0.00% | +33.3% |
| Q3 2019 | $1,635,000 | – | 107,734 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,355,392 | $29,859,000 | 6.21% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $67,858,000 | 4.26% |
| DAFNA Capital Management LLC | 587,756 | $12,948,000 | 3.85% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 227,388 | $5,009,000 | 2.91% |
| RTW INVESTMENTS, LP | 7,253,857 | $159,802,000 | 2.68% |
| Parkman Healthcare Partners LLC | 331,513 | $7,303,000 | 1.87% |
| Evolutionary Tree Capital Management, LLC | 60,864 | $1,341,000 | 1.02% |
| Eagle Health Investments LP | 69,000 | $1,520,000 | 0.97% |
| Woodline Partners LP | 1,358,796 | $29,934,000 | 0.79% |
| Affinity Asset Advisors, LLC | 40,000 | $881,000 | 0.47% |